FDA Inspection 1215614 — Montefiore's Institute For Reproductive Medicine And Health
The FDA completed an inspection of Montefiore's Institute For Reproductive Medicine And Health on Aug 16, 2023 in Hartsdale, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hartsdale, NY (United States)